ASCO 2026: Genomics Reveal HRD–Treatment Response Link

• June 5, 2026

ASCO 2026: AI Challenges a Breast Cancer Standard

New data suggest AI-based analysis of pathology slides may provide additional prognostic information, particularly for patients in the intermediate-risk category

• by Jessica Allerton

• June 4, 2026

• 3 min

Case Report: Cytokeratin-positive interstitial reticulum cell tumor with HLA loss of heterozygosity

• by Wen Liu, Yan Zhang, Yuqing Wei, Yinan Hu, Xinmiao Zhang, Jingli Xue, Peifeng Li

• June 2, 2026

Target receptor expression dictates the selective intra-tumoral targeting of CD8+ T cells by eciskafusp alfa in matched PBMCs and TILs from CPI-naïve patients

• by Amrita Manchala, Eleni Maria Varypataki, Jehad Charo, Pablo Umaña, Christian Klein, Laura Codarri Deak

• June 1, 2026